Swiss National Bank trimmed its stake in Regeneron Pharmaceuticals, Inc. by a modest 0.5%. Despite this, Regeneron's share ...

Bristol-Myers Squibb faces a challenging market landscape. Bearish technical signals and volatile price movements mark its ...